Build status - In Progress

Study of and Investigational drug in Participants with Advanced Renal Cell Carcinoma That Has Progressed

Study of and Investigational drug in Participants with Advanced Renal Cell Carcinoma That Has Progressed
Recruiting
18 years - 99 years
All
Phase N/A
50 participants needed
1 Location

Brief description of study

The research study is being conducted to evaluate the safety and effectiveness of MK-6482 when compared to treatment with everolimus for renal cell carcinoma.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Renal Cell Carcinoma,Cancer
  • Age: 18 years - 99 years
  • Gender: All

Male or Female Age 18 or older Has locally advanced or metastatic clear cell renal cell carcinoma (RCC)

Updated on 04 Aug 2024. Study ID: 842957

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center